Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 3, 2008, Pages 582-596

  Jiang, Shujia ^a   Kh Haider, Husnain ^a   Ahmed, Rafeeq P H ^a   Idris, Niagara M ^a   Salim, Asmat ^a   Ashraf, Muhammad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Angiogenesis; Myocardial infarction; Myocardium; Myogenesis; Stem cells; Transplantation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; GROWTH FACTOR; P21 ACTIVATED KINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOXIA; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTRON MICROSCOPY; GENETIC TRANSCRIPTION; HEART FUNCTION; HEART INFARCTION; MALE; MESENCHYMAL STEM CELL; MUSCLE DEVELOPMENT; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

AGE FACTORS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON; MYOCARDIAL INFARCTION; MYOCARDIUM; OXYGEN; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; RATTUS;

EID: 40649113341     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.11.014     Document Type: Article

References (34)

1. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95 (2004) 9-20
2. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
3. Kawada H., Fujita J., Kinjo K., Matsuzaki Y., Tsuma M., Miyatake H., et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104 (2004) 3581-3587
4. Schwartz R.E., Reyes M., Koodie L., Jiang Y., Blackstad M., Lund T., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109 (2002) 1291-1302
5. Dai W., Hale S.L., Martin B.J., Kuang J.Q., Dow J.S., Wold L.E., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112 (2005) 214-223
6. Nagaya N., Kangawa K., Itoh T., Iwase T., Murakami S., Miyahara Y., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005) 1128-1135
7. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12 (2006) 459-465
8. Pak H.N., Qayyum M., Kim D.T., Hamabe A., Miyauchi Y., Lill M.C., et al. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J Cardiovasc Electrophysiol 14 (2003) 841-848
9. Takahashi M., Li T.S., Suzuki R., Kobayashi T., Ito H., Ikeda Y., et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 291 (2006) H886-H893
10. Tang Y.L., Zhao Q., Qin X., Shen L., Cheng L., Ge J., and Phillips M.I. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80 (2005) 229-236 (discussion 236-7)
11. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94 (2004) 678-685
12. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
13. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98 (2006) 1414-1421
14. Edelberg J.M., Tang L., Hattori K., Lyden D., and Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90 (2002) E89-E93
15. Rossi D.J., Bryder D., Zahn J.M., Ahlenius H., Sonu R., Wagers A.J., et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A 102 (2005) 9194-9199
16. Fehrer C., Laschober G., and Lepperdinger G. Aging of murine mesenchymal stem cells. Ann N Y Acad Sci 1067 (2006) 235-242
17. Zimmermann S., Voss M., Kaiser S., Kapp U., Waller C.F., and Martens U.M. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17 (2003) 1146-1149
18. Stolzing A., Sethe S., and Scutt A.M. Stressed stem cells: temperature response in aged mesenchymal stem cells. Stem Cells Dev. 15 (2006) 478-487
19. Li T.S., Hamano K., Suzuki K., Ito H., Zempo N., and Matsuzaki M. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol 283 (2002) H468-H473
20. Jiang S., Haider H., Idris N.M., Salim A., and Ashraf M. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res 99 (2006) 776-784
21. Niagara M.I., Haider H., Jiang S., and Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100 (2007) 545-555
22. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109 (2004) 1543-1549
23. Silva G.V., Litovsky S., Assad J.A., Sousa A.L., Martin B.J., Vela D., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111 (2005) 150-156
24. Li T.S., Furutani A., Takahashi M., Ohshima M., Qin S.L., Kobayashi T., et al. Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats. Am J Physiol Heart Circ Physiol 290 (2006) H1362-H1369
25. Kang M.J., Kim H.J., Kim H.K., Lee J.Y., Kim D.H., Jung K.J., et al. The effect of age and calorie restriction on HIF-1-responsive genes in aged liver. Biogerontology 6 (2005) 27-37
26. Haynesworth S.E., Baber M.A., and Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 166 (1996) 585-592
27. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., and Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176 (1998) 57-66
28. Wagatsuma A. Effect of aging on expression of angiogenesis-related factors in mouse skeletal muscle. Exp Gerontol 41 (2006) 49-54
29. Edwards M.G., Anderson R.M., Yuan M., Kendziorski C.M., Weindruch R., and Prolla T.A. Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics 8 (2007) 80
30. Blagosklonny M.V. Are p27 and p21 cytoplasmic oncoproteins?. Cell Cycle 1 (2002) 391-393
31. Thum T., Hoeber S., Froese S., Klink I., Stichtenoth D.O., Galuppo P., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 100 (2007) 434-443
32. Sethe S., Scutt A., and Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 5 (2006) 91-116
33. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
34. + mesenchymal stem cells. Eur J Heart Fail 8 (2006) 555-563